CONCORD DRUGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.57 INR | +2.38% |
|
+5.60% | -33.74% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Concord Drugs Limited is an India-based pharmaceutical company. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company offers finished pharmaceutical formulations, such as injectables (small volume parenteral, dry powders), tissue bio-adhesive, tablets, capsules, liquid orals (syrup and suspension) and dry syrups (powder). The Company also provides ready-to-fill pellets and multiple unit pellet system (MUPS). Its injectables include Amikacin Injection, Aceclofenac Injection, Artemether Injection, Adenosine Injection, and others. Iso Amyl 2-Cyano Acrylate is a tissue bio-adhesive. Its pellets are categorized as gastrointestinal drug pellets, cardiovascular drug pellets, respiratory drug pellets, anti-obesity drug pellets, anti-depressant drug pellets, central nervous system drug pellets, urological drug pellets, anti-microbial, anti-infective and adjuvant drugs pellets, taste mask drug pellets/powder, and others.
Sector
Pharmaceuticals
Calendar
13/08/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -33.74% | 4.63M | |
| +54.07% | 816B | |
| +38.59% | 634B | |
| -7.05% | 351B | |
| +15.44% | 323B | |
| +5.72% | 293B | |
| +13.40% | 238B | |
| +0.61% | 222B | |
| +13.24% | 218B | |
| +7.42% | 167B |
- Stock Market
- Equities
- CONCORD6 Stock
- News Concord Drugs Limited
- Concord Drugs Eyes INR 207 Million Rights Issue
